The azide group (-N₃) has emerged as one of the most versatile chemical handles in peptide chemistry, primarily due to its central role in click chemistry reactions. This small, bioorthogonal functional group enables the selective conjugation of peptides to a vast array of molecules, including fluorophores, drugs, oligonucleotides, and surfaces, under mild, physiologically compatible conditions. However, the decision to incorporate an azide into a peptide sequence requires careful consideration of the intended application, the availability of compatible conjugation partners, and the potential impact on peptide synthesis and stability. This article provides a framework for evaluating whether an azide modification aligns with your research objectives.

Key Takeaways

• An azide group serves as a bioorthogonal handle for click chemistry, enabling specific conjugation without interfering with native biological functions.
• Two primary click chemistry pathways exist: copper-catalyzed azide-alkyne cycloaddition (CuAAC) and copper-free strain-promoted azide-alkyne cycloaddition (SPAAC) using DBCO or related cyclooctynes.
• Copper-free methods are strongly preferred for biological applications involving live cells, proteins, or sensitive biomolecules, as copper ions can cause denaturation and toxicity.
• Azide incorporation is most commonly achieved at the N-terminus or on lysine side chains using commercially available Fmoc-protected azido-amino acid building blocks.
• Alternative bioorthogonal strategies, such as methyltetrazine-trans-cyclooctene (TCO) IEDDA reactions, may offer faster kinetics for certain applications.

Introduction to the Azide Functional Group in Peptides

What Makes the Azide Group Unique?

The azide moiety is a small, linear functional group consisting of three nitrogen atoms in a chain. Its value in peptide chemistry stems from three key properties:

1. Bioorthogonality: Azides are absent from native biological systems, meaning they do not react with endogenous functional groups such as amines, thiols, or carboxylates.
2. Selective Reactivity: Azides undergo highly specific cycloaddition reactions with alkynes, particularly strained cyclooctynes, forming stable 1,2,3-triazole linkages.
3. Small Size: Minimal steric footprint reduces the likelihood of interfering with peptide folding, receptor binding, or biological activity.

The Click Chemistry Revolution

The discovery that azides and alkynes could be linked under mild conditions, coined “click chemistry” and recognized with the 2022 Nobel Prize in Chemistry, has transformed bioconjugation. Two principal approaches dominate peptide applications:

• CuAAC (Copper-Catalyzed Azide-Alkyne Cycloaddition): Utilizes a copper(I) catalyst to drive the reaction between an azide and a terminal alkyne. While highly efficient, the copper catalyst can damage sensitive biomolecules and is toxic to living systems.
• SPAAC (Strain-Promoted Azide-Alkyne Cycloaddition): Employs strained cyclooctynes such as DBCO (dibenzocyclooctyne) or BCN, eliminating the need for a copper catalyst. This “copper-free click chemistry” proceeds under physiological conditions and is compatible with live cells and organisms.

Find out more about peptide synthesis here.

Decision Framework: When to Include an Azide Group

Consideration 1: Your Primary Application

For Bioconjugation to Complex Biomolecules

If your goal is to conjugate a peptide to an antibody, protein, or oligonucleotide, including an azide is an excellent strategy. The standard workflow involves:

1. Activating the target molecule (e.g., antibody) with a DBCO-NHS ester, which attaches DBCO groups to surface lysines.
2. Reacting the DBCO-functionalized target with your azide-modified peptide under mild conditions (PBS, 4°C to room temperature, overnight).

This approach yields stable triazole-linked conjugates without the need for toxic catalysts. It has been successfully applied to antibody-DNA conjugates, antibody-drug conjugates, and antibody-peptide systems.

For Fluorescent Labeling and Imaging

Azide-modified peptides can be conjugated to alkyne- or DBCO-functionalized fluorophores for cellular imaging applications. Recent advances have demonstrated rapid and quantitative labeling of azide-containing peptides using copper-chelating azide designs that accelerate CuAAC reactions by up to three orders of magnitude compared to traditional catalysts.

For Peptide-Peptide Ligation and Cyclization

Azide groups enable the joining of peptide fragments or the formation of cyclic peptides. By incorporating an azide on one fragment and an alkyne on another, a triazole bridge can be formed that mimics an amide bond while conferring resistance to enzymatic degradation. This approach has been used to create stapled peptides with enhanced helical content and stability.

Consideration 2: Available Click Chemistry Partners

Before committing to an azide modification, verify that you have access to a compatible alkyne- or DBCO-functionalized conjugation partner. Common options include:

Consideration 3: Alternative Bioorthogonal Handles

While azides are powerful, they are not the only option. Methyltetrazine-maleimide linkers offer an alternative bioorthogonal strategy via inverse electron-demand Diels-Alder (IEDDA) reactions with TCO or norbornene partners. These reactions are among the fastest bioorthogonal ligations known, completing in minutes rather than hours. The choice between azide and tetrazine often depends on:

• Kinetic requirements: IEDDA is significantly faster than SPAAC.
• Partner availability: Azide-DBCO pairs are more widely commercially available.
• Application context: Live-cell labeling may favor one over the other based on background reactivity.

Synthesis and Incorporation Strategies

Where to Place the Azide Group

Azides can be incorporated at multiple positions within a peptide sequence:

• N-terminus: Using azido-acetic acid or Fmoc-protected azido-amine building blocks during solid-phase peptide synthesis (SPPS).
• Lysine side chains: Using commercially available Fmoc-Lys(N₃)-OH or Fmoc-Lys(azide)-OH building blocks.
• C-terminus: Achieved through specialized resins or solution-phase modification.

Protecting Group Considerations

When incorporating azide-functionalized amino acids, standard Fmoc/tBu SPPS is compatible, provided the azide group is stable to the acidic and basic conditions used in synthesis and cleavage. Fmoc-protected ω-azido-L-amino acids are commercially available for introducing azides at various chain lengths.

Purification and Stability

Azide-containing peptides should be purified by standard reverse-phase HPLC and stored desiccated at -20°C. The azide group is generally stable under these conditions but may be reduced to a primary amine by strong reducing agents such as dithiothreitol (DTT) or tris(2-carboxyethyl)phosphine (TCEP), a consideration if your peptide also contains disulfide bonds.

Find out about high-speed RUSH synthesis.

Frequently Asked Questions (FAQ)

What is the difference between CuAAC and SPAAC click chemistry?

CuAAC (copper-catalyzed azide-alkyne cycloaddition) requires a copper(I) catalyst to facilitate the reaction between an azide and a terminal alkyne. SPAAC (strain-promoted azide-alkyne cycloaddition) uses strained cyclooctynes such as DBCO and proceeds without a catalyst. For biological applications involving live cells, proteins, or sensitive biomolecules, copper-free SPAAC is strongly preferred to avoid copper-induced toxicity and denaturation.

Can I incorporate an azide into any peptide sequence?

Yes, azides can be incorporated at the N-terminus, on lysine side chains, or at the C-terminus using commercially available building blocks. However, careful design is needed if the peptide contains other reactive groups (e.g., disulfide bonds) that may interfere with subsequent click reactions.

Is the azide group stable during peptide synthesis?

Yes. The azide group is stable under standard Fmoc SPPS conditions, including exposure to piperidine for deprotection and TFA for cleavage. However, it may be reduced by strong reducing agents such as DTT or TCEP.

Sinozaki, Y., Otani, R., Tanimoto, H., & Tomohiro, T. (2025). Synthesis and Application of Azide‐Incorporated Copper‐Chelating Peptides for Efficient Click Conjugation Reaction. Journal of Heterocyclic Chemistry, 62(7), 419–429. https://doi.org/10.1002/jhet.4955

Rathinam, S., Sørensen, K. K., Hjálmarsdóttir, M. Á., Thygesen, M. B., & Másson, M. (2024). Conjugation of CRAMP18–35 Peptide to Chitosan and Hydroxypropyl Chitosan via Copper-Catalyzed Azide–Alkyne Cycloaddition and Investigation of Antibacterial Activity. International Journal of Molecular Sciences, 25(17), 9440. https://doi.org/10.3390/ijms25179440

2,6-Diaminopimelic acid (DAP) is a unique non-proteinogenic diamino acid that occupies a unique position at the intersection of bacterial physiology, antibiotic development, and synthetic peptide chemistry. Structurally characterized as an α,α′-diamino dicarboxylic acid with the molecular formula C7H14N2O4, DAP is distinguished by the presence of two chiral centers and two amino groups flanking a seven-carbon backbone. This unusual amino acid is an essential constituent of bacterial peptidoglycan and serves as the biosynthetic precursor to L-lysine in both bacteria and higher plants. Importantly, mammals lack this entire metabolic pathway and require lysine as a dietary essential amino acid, making DAP and its processing enzymes attractive targets for antibiotic development with minimal mammalian toxicity. Beyond its native biological roles, DAP has emerged as a valuable building block in synthetic peptide chemistry, enabling the creation of structurally constrained peptides with potential immunostimulant, antitumor, and sleep-inducing activities.

Key Takeaways

• 2,6-Diaminopimelic acid is a symmetrical diamino dicarboxylic acid with the molecular formula C7H14N2O4 and CAS number 583-93-7, existing in three stereoisomeric forms: LL-, DD-, and meso-DAP.
• The meso-DAP isomer is an essential cross-linking component of peptidoglycan in Gram-negative bacterial cell walls, while Gram-positive bacteria typically use L-lysine for this function.
• DAP is the biosynthetic precursor to L-lysine in bacteria and plants via the diaminopimelate pathway, a route completely absent in mammals.
• Analogues of DAP, including fluorinated, phosphonate, and heterocyclic derivatives, have demonstrated significant antibacterial activity by inhibiting key enzymes in the DAP/lysine biosynthesis pathway.
• In peptide synthesis, DAP enables the construction of unusual peptides with C-termini at both ends, as well as complex structures incorporating diketopiperazine rings, which exhibit diverse biological activities.
• Custom synthesis of DAP-containing peptides for research applications is available through specialized providers like LifeTein, enabling studies of bacterial enzymes, immunomodulatory compounds, and potential therapeutic agents.

Chemical Fundamentals of 2,6-Diaminopimelic Acid

Structural Characteristics and Stereochemistry of DAP

2,6-Diaminopimelic acid is defined by its symmetrical structure: a seven-carbon dicarboxylic acid backbone with amino groups at both the C2 and C6 positions. The IUPAC name, 2,6-diaminoheptanedioic acid, accurately describes this arrangement.

The presence of two stereogenic centers gives rise to three possible stereoisomers: the LL-isomer (both chiral centers in the L-configuration), the DD-isomer (both in the D-configuration), and the meso-isomer (one center L, one center D). This stereochemical diversity is biologically critical, as different isomers serve distinct functions in bacterial metabolism and cell wall architecture.

Natural Occurrence and Biosynthetic Context

DAP is a naturally occurring amino acid found in both bacteria and higher plants. Its discovery by Work in 1950 marked an important milestone in understanding bacterial cell wall composition. In nature, DAP is biosynthesized through the diaminopimelate pathway, which converts pyruvate and L-aspartate into L-lysine, with meso-DAP serving as the immediate precursor to lysine.

The pathway involves several enzymes that have become targets for antibiotic development, including diaminopimelate epimerase (DapF), which catalyzes the interconversion of LL-DAP and meso-DAP, and diaminopimelate decarboxylase, which converts meso-DAP to L-lysine.

Find out more about peptide synthesis here.

Biological Significance and Therapeutic Relevance of DAP

Essential Role in Bacterial Peptidoglycan

The most critical biological function of DAP lies in its contribution to bacterial cell wall integrity. In Gram-negative bacteria, the meso-DAP isomer is incorporated into the peptidoglycan layer, where it acts as a cross-linking agent between glycan strands. Specifically, meso-DAP in the pentapeptide of peptidoglycan provides the attachment site that links the inner and outer membranes to the rigid cell wall structure.

This function is absolutely essential for bacterial survival; disruption of DAP incorporation or biosynthesis leads to weakened cell walls and osmotic lysis. Importantly, because mammals lack DAP and its metabolic pathway, inhibitors targeting DAP utilization exhibit minimal mammalian toxicity, fulfilling the ideal criteria for antibiotic development.

The DAP/Lysine Biosynthetic Pathway as an Antibiotic Target

The diaminopimelate pathway represents a validated target for novel antibacterial agents . Multiple enzymes in this pathway have been structurally characterized and exploited for inhibitor design:

Research has demonstrated that certain DAP analogues achieve up to 75% growth inhibition against bacterial strains, validating this approach for antibiotic discovery.

DAP Synthetic Approaches and Peptide Applications

Stereocontrolled Synthesis of DAP-Containing Peptides

The incorporation of DAP into synthetic peptides presents both opportunities and challenges due to its two amino groups and stereochemical complexity. Researchers have developed sophisticated stereocontrolled synthetic strategies to access DAP-containing peptides with defined configurations.

One elegant approach utilizes a chiral synthon derived from L-valine, specifically, a mono-lactim ether that serves as a template for constructing the DAP framework . Alkylation with dihaloalkanes followed by elaboration yields optically active tripeptides with the general structure Val-(DAP)-Val, representing unusual peptides that are C-terminal at both ends of the chain. These compounds are valuable for studying structure-activity relationships and enzyme inhibition.

Complex Peptide Architectures

Beyond simple linear peptides, DAP enables the construction of conformationally constrained structures with diverse biological activities. Researchers have synthesized peptides incorporating a proline residue fused to a diketopiperazine ring containing the DAP skeleton. These fused ring systems resemble natural products such as brevianamides, which exhibit immunomodulatory, antitumor, and antibiotic properties.

X-ray crystallography and computational modeling of these DAP-containing peptides have revealed important structural features, including the planar conformation of diketopiperazine rings and the influence of proline residues on overall molecular geometry. Such insights guide the rational design of peptide-based therapeutics.

Biologically Active Peptide Analogues

Several classes of DAP-containing peptides have demonstrated promising biological activities:

• γ-Glutamyl-diaminopimelic acid dipeptides: Synthesized via regioselective ring-opening strategies, these compounds show potential as immunostimulating agents .
• Hydrazino-dipeptide analogues: Designed as inhibitors of DAP aminotransferase, these compounds exhibit potent, slow-binding inhibition and antimicrobial activity against both Gram-positive and Gram-negative bacteria.
• Phosphonate-containing DAP peptides: While the phosphonate analogues themselves showed weak enzyme inhibition, certain tripeptide derivatives demonstrated growth inhibition against specific bacterial strains.
• Acylated DAP peptides: Conjugation of DAP-containing peptides with lauric or palmitic acid yields compounds with immunoadjuvant activity.

Research Applications and Custom Synthesis

Tools for Studying Bacterial Enzymology

DAP and its analogues serve as indispensable tools for probing bacterial enzyme mechanisms. Researchers studying DAP epimerase, DAP dehydrogenase, and MurE rely on synthetic DAP-containing substrates and inhibitors to elucidate catalytic mechanisms and to screen for potential antibiotics. The availability of fluorinated, aziridino, and phosphonate derivatives enables detailed structure-activity relationship studies.

Availability from Commercial Sources

For research applications, high-quality DAP and custom DAP-containing peptides are available from specialized suppliers. LifeTein offers expertise in incorporating unusual amino acids like DAP into custom peptide sequences, enabling researchers to access complex structures for their specific investigations. These services include:

• Synthesis of DAP-containing peptides with defined stereochemistry
• Incorporation of DAP into cyclic peptides and constrained structures
• Production of DAP analogues for enzyme inhibition studies
• Rigorous quality control, including HPLC and mass spectrometry validation

Find out about high-speed RUSH synthesis.

Frequently Asked Questions (FAQ)

What is the difference between the three stereoisomers of DAP?

2,6-Diaminopimelic acid exists as LL-, DD-, and meso-isomers due to its two chiral centers. The LL-isomer has both amino groups in the L-configuration, the DD-isomer has both in the D-configuration, and the meso-isomer has one L and one D center. The meso-DAP isomer is the biologically relevant form incorporated into bacterial peptidoglycan and serves as the immediate precursor to L-lysine.

Why is DAP considered a target for antibiotic development?

Mammals lack the entire diaminopimelate pathway and require dietary lysine, whereas bacteria depend on this pathway to synthesize both meso-DAP (for peptidoglycan) and L-lysine (for protein synthesis). Consequently, inhibitors targeting DAP biosynthesis enzymes or DAP incorporation into peptidoglycan exhibit selective antibacterial activity with minimal mammalian toxicity.

What types of DAP analogues have shown antibacterial activity?

Several classes of DAP analogues demonstrate promising antibacterial effects, including fluorinated derivatives, aziridino-DAP (extremely potent against DAP epimerase), isoxazoline-containing analogues, phosphonate derivatives, and hydrazino-dipeptides. Some analogues achieve up to 75% growth inhibition against bacterial strains.

How is DAP incorporated into synthetic peptides?

DAP incorporation requires orthogonal protecting group strategies due to its two amino groups. Researchers typically use stereocontrolled synthesis starting from chiral synthons like mono-lactim ethers derived from valine. Specialized peptide synthesis providers such as LifeTein offer custom synthesis of DAP-containing peptides with defined stereochemistry and high purity.

Paradisi, F., Porzi, G., & Sandri, S. (2001). A new stereocontrolled synthesis of uncommon tripeptides derived from 2,6-diaminopimelic acid (2,6-DAP). Tetrahedron: Asymmetry, 12(23), 3319–3324. https://doi.org/10.1016/s0957-4166(02)00002-2

Galeazzi, R., Garavelli, M., Grandi, A., Monari, M., Porzi, G., & Sandri, S. (2003). Unusual peptides containing the 2,6-diaminopimelic acid framework: Stereocontrolled synthesis, X-ray analysis, and computational modelling. Part 2. Tetrahedron: Asymmetry, 14(17), 2639–2649. https://doi.org/10.1016/s0957-4166(03)00541-x

Chatterjee, B., Mondal, D., & Bera, S. (2021). Diaminopimelic acid and its analogues: Synthesis and biological perspective. Tetrahedron, 100, 132403. https://doi.org/10.1016/j.tet.2021.132403

Fluorescent labelling with Cy7 has emerged as a cornerstone technology in advanced biomedical imaging, enabling researchers to visualize biological processes with unprecedented depth and clarity. As a member of the heptamethine cyanine dye family, Cy7 is characterized by its exceptional near-infrared (NIR) fluorescence properties, with excitation and emission maxima at approximately 749 nm and 776 nm, respectively. This spectral positioning within the NIR optical window (650–900 nm) minimizes interference from endogenous biomolecules like hemoglobin and water, allowing for deep tissue penetration of up to 15 cm and significantly reducing background autofluorescence. The strategic application of Cy7 labelling has revolutionized fields ranging from in vivo imaging and photodynamic therapy to drug delivery systems, with recent advances even witnessing a Cy7-based theranostic agent enter clinical trials. Understanding the principles, methodologies, and applications of Cy7 conjugation is therefore essential for researchers seeking to leverage this powerful tool in their investigations.

Key Takeaways

• Cy7 exhibits excitation/emission maxima at ~749/776 nm, placing it within the ideal NIR window for deep-tissue imaging with minimal background interference.
• The dye’s heptamethine structure enables dual functionality as both a fluorescent probe and a photosensitizer for photodynamic and photothermal therapies.
• Conjugation typically employs NHS ester chemistry targeting primary amines or maleimide chemistry for thiol-specific labelling, with reaction conditions carefully optimized to preserve biomolecular activity.
• Cy7-labelled peptides and proteins are indispensable tools in in vivo imaging, theranostic agent development, and studies of cell-cell interactions such as the LIPSTIC technique.

Fundamentals of Cy7 Structure and Photophysics

Chemical Architecture of Heptamethine Cyanine Dyes

The molecular structure of Cy7 is defined by a central conjugated polymethine chain connecting two nitrogen-containing indole heterocycles. This heptamethine framework creates an extensive π-conjugated system responsible for the dye’s strong absorption in the NIR region. One indole moiety carries a positive charge, resulting in a delocalized cationic structure that influences both the dye’s photophysical behavior and its interaction with biological environments. This unique architecture not only confers exceptional brightness but also enables structural modifiability at multiple sites, allowing researchers to fine-tune properties such as water solubility, targeting specificity, and photosensitizing efficiency.

Spectral Advantages and the NIR Optical Window

The placement of Cy7’s fluorescence within the NIR region is of paramount biological significance. Between 650 nm and 900 nm, light absorption by hemoglobin, water, and lipids is minimal, creating a “therapeutic window” where photons can penetrate tissues deeply without significant attenuation. Consequently, Cy7-labelled probes can be visualized through several centimeters of tissue, making them ideal for whole-animal imaging studies, intraoperative guidance, and deep-tumor visualization. Furthermore, the absence of endogenous NIR fluorescence in most biological specimens ensures exceptionally low background signals, dramatically improving the signal-to-noise ratio in imaging experiments.

Find out more about fluorescent peptides here.

Conjugation Chemistry and Methodologies

NHS Ester Chemistry for Amine Labelling

The most prevalent strategy for Cy7 conjugation targets primary amine groups present on lysine residues or protein N-termini. This approach utilizes Cy7-NHS ester derivatives, where the N-hydroxysuccinimide moiety acts as a leaving group upon nucleophilic attack by the amine. The reaction proceeds efficiently under mild, weakly alkaline conditions (pH 7.4–8.5), forming a stable amide bond that covalently links the dye to the biomolecule. Researchers must carefully control the molar ratio of dye to protein, typically ranging from 3:1 to 10:1, to achieve optimal labelling density while avoiding excessive modification that could compromise biological function.

Maleimide Chemistry for Thiol-Specific Conjugation

For applications requiring site-specific labelling, maleimide-functionalized Cy7 offers an elegant solution by targeting the thiol groups of cysteine residues. This Michael addition reaction proceeds rapidly under physiological conditions and provides positional control when cysteines are strategically introduced into peptide sequences. In some cases, mild reduction may be necessary to expose previously oxidized or disulfide-bonded thiols before conjugation.

Reaction Optimization and Purification

Successful Cy7 labelling demands meticulous attention to reaction parameters. Temperature control, typically maintained at 4–25°C, prevents protein denaturation while ensuring adequate reaction kinetics. Light protection throughout the procedure is essential to prevent photodegradation of the dye. Following conjugation, removal of unreacted dye is accomplished through gel filtration chromatography, dialysis, or HPLC purification, yielding high-purity conjugates suitable for sensitive biological applications.

Applications in Biomedical Research

In Vivo Imaging and Biodistribution Studies

Cy7’s deep-tissue imaging capabilities have made it indispensable for tracking biodistribution, tumor targeting, and pharmacokinetics in living animals. Fluorescently labelled peptides and proteins administered to murine models can be non-invasively monitored over time, providing real-time insights into accumulation patterns at target sites. For example, Cy7-conjugated LPETGG peptides have been employed to visualize immune cell interactions in preclinical cancer models, leveraging the dye’s NIR emission to penetrate through tissues and reveal dynamic cellular processes.

Photodynamic and Photothermal Therapy

Beyond imaging, certain Cy7 derivatives function as potent photosensitizers for cancer therapy. Upon NIR light activation, these molecules generate reactive oxygen species (ROS) or heat, inducing apoptosis in targeted tumor cells. Recent innovations have produced asymmetric Cy7 dyes with remarkably high singlet oxygen quantum yields (ΦΔ up to 1.84), enabling effective photodynamic therapy at previously unattainable depths. Importantly, these agents exhibit cancer cell specificity by leveraging microenvironmental features such as elevated viscosity, while demonstrating negligible dark cytotoxicity.

Studying Cell-Cell Interactions with LIPSTIC

In immunology research, Cy7-labelled LPETGG peptides have proven instrumental in the LIPSTIC (Labelling Immune Partnerships by SorTagging Intercellular Contacts) technique. This elegant method uses bacterial sortase A to enzymatically transfer fluorescent dyes from the LPETGG substrate onto interacting cell surfaces, enabling researchers to track dynamic immune partnerships in vivo and in vitro with single-cell resolution. Such applications underscore the versatility of Cy7 beyond simple structural labelling.

Selecting Cy7 for Your Research

Advantages Over Shorter-Wavelength Dyes

When compared to visible-light fluorophores like Cy3 or fluorescein, Cy7 offers distinct advantages for whole-animal studies, deep-tissue imaging, and multiplexing experiments where spectral separation is required. Its NIR emission avoids overlap with common fluorescent proteins and organic dyes, facilitating multicolor panels.

Availability from Commercial Sources

High-quality Cy7 derivatives and pre-labelled peptides are readily available from specialized suppliers. LifeTein, for example, offers Cy7 conjugation on custom peptides such as the LPETGG motif, providing researchers with versatile tools for sortase-mediated labelling and imaging applications. These products undergo rigorous quality control, including HPLC and mass spectrometry validation, ensuring reproducibility in demanding experiments.

Find out more about peptide synthesis here.

Frequently Asked Questions (FAQ)

What are the exact excitation and emission maxima for Cy7?

Cy7 exhibits peak excitation at approximately 749 nm and peak emission at approximately 776 nm, placing it squarely within the near-infrared window optimal for deep-tissue imaging.

How does Cy7 compare to Cy5 or Cy5.5 for in vivo work?

While Cy5 (670 nm emission) and Cy5.5 (701 nm emission) are excellent for many applications, Cy7’s longer wavelength offers superior tissue penetration and lower background due to reduced scattering and absorption by endogenous chromophores. The choice depends on the required depth of imaging and compatibility with available instrumentation.

What conjugation chemistries are available for Cy7?

Cy7 is commonly supplied as an NHS ester for amine coupling or as a maleimide derivative for thiol-specific labelling. The NHS ester is preferred for lysine residues and N-termini, while maleimide enables site-specific conjugation to engineered cysteine residues. Site-specific conjugation via click chemistry is also an option using methods such as Cy7-DBCO and a lys(N3) residue.

Can Cy7 be used for photodynamic therapy?

Yes, certain Cy7 derivatives function as effective photosensitizers, generating reactive oxygen species upon NIR light activation. Recent advances have produced dyes with exceptionally high singlet oxygen quantum yields, making them suitable for photodynamic ablation of tumors.

How stable are Cy7-labelled peptides during storage?

Cy7 conjugates should be protected from light and stored desiccated at -20°C for long-term stability. Reconstituted materials may be stored for up to two weeks at -20°C in aliquots to avoid repeated freeze-thaw cycles.

Are Cy7-labelled peptides available commercially for research?

Yes, specialized providers such as LifeTein offer custom synthesis of Cy7-labelled peptides with high purity (>95%) and rigorous analytical validation. These products are suitable for in vivo imaging, flow cytometry, and advanced techniques like LIPSTIC.

Long, L., Cao, X., Shi, X., Zhang, J., & Shi, C. (2025). Modifications and applications of heptamethine cyanine (Cy7) dyes as near-infrared photosensitizers. Coordination Chemistry Reviews, 541, 216780. https://doi.org/10.1016/j.ccr.2025.216780

Khaikate, O., Muangsopa, P., Piyanuch, P., Khrootkaew, T., Wiriya, N., Chansaenpak, K., Sukwattanasinitt, M., & Kamkaew, A. (2024). Asymmetric heptamethine cyanine dye for viscosity detection and photodynamic therapy. Journal of Photochemistry and Photobiology A: Chemistry, 453, 115659. https://doi.org/10.1016/j.jphotochem.2024.115659

2,4-Diaminobutyric acid (DAB) is a fascinating non-proteinogenic diamino acid that has garnered significant attention in peptide chemistry and biomedical research. Structurally characterized by the presence of two amino groups at the alpha and gamma positions of a four-carbon backbone, this unusual amino acid serves as a versatile building block for creating peptides with unique structural and functional properties. Unlike standard amino acids encoded by the genetic code, DAB must be incorporated into peptides through specialized synthetic strategies, making it a valuable tool for researchers seeking to introduce additional charge, hydrogen-bonding capacity, or conformational constraints into their peptide sequences. Its biological significance extends beyond synthetic utility, as DAB occurs naturally in various organisms and exhibits interesting pharmacological activities, including interactions with neurotransmitter systems and potential anticancer properties.

Key Takeaways

• 2,4-Diaminobutyric acid (DAB) is a non-proteinogenic diamino acid with the molecular formula C4H10N2O2 and a structure featuring amino groups at both the 2-position (alpha) and 4-position (gamma) of the butyric acid backbone.
• DAB exists as two stereoisomers, L-DAB and D-DAB, which exhibit markedly different biological activities. The S(+) isomer is at least 20 times more potent than the R(-) isomer at inhibiting GABA uptake in neuronal tissues.
• In peptide synthesis, DAB requires orthogonal protecting group strategies, commonly using derivatives like Dde-DAB(Fmoc)-OH, to enable selective deprotection and site-specific functionalization during solid-phase peptide synthesis.
• DAB-containing peptides have demonstrated antitumoral activity against human glioma cells, attributed to concentrated uptake leading to osmotic cellular lysis.
• The incorporation of DAB into cyclic dipeptides enables the formation of conformationally constrained structures, such as 5-membered lactam rings, which are valuable for studying protein structure-function relationships.

Chemical Fundamentals of 2,4-Diaminobutyric Acid

Definition and Structural Characteristics of DAB

2,4-Diaminobutyric acid is formally defined as a diamino acid derived from butyric acid, wherein hydrogen atoms at positions 2 and 4 are replaced by amino groups. Its molecular formula is C4H10N2O2, with an average mass of 118.13 g/mol. The compound features an alpha amino group adjacent to the carboxylic acid and a gamma amino group at the end of the aliphatic chain, creating a structure with two positively charged centers at physiological pH. This dual cationic character distinguishes DAB from standard amino acids and imparts unique physicochemical properties, including enhanced water solubility and the ability to participate in multiple hydrogen-bonding interactions.

Isomeric Forms and Stereochemistry

A critical aspect of DAB chemistry is its existence as two distinct stereoisomers due to the chiral center at the alpha carbon. The L-isomer (S-configuration) and D-isomer (R-configuration) exhibit profound differences in their biological activities. Research has demonstrated that S(+)-2,4-diaminobutyric acid is approximately 20 times more potent than the R(-) stereoisomer as an inhibitor of sodium-dependent GABA uptake in rat brain slices. Interestingly, both isomers display equipotent inhibition of sodium-independent GABA binding to brain membranes, suggesting that the stereospecificity relates specifically to transporter interactions rather than receptor binding. This stereochemical discrimination underscores the importance of using the correct isomer when designing DAB-containing peptides for neurobiological applications.

Find out more about peptide synthesis here.

DAB Applications in Peptide Synthesis

Orthogonal Protection Strategies

The incorporation of DAB into synthetic peptides presents unique challenges due to the presence of two reactive amino groups that must be differentially protected during solid-phase peptide synthesis (SPPS). Commercial suppliers offer specialized derivatives such as Dde-DAB(Fmoc)-OH (CAS 1263045-85-7), which features both Dde and Fmoc protecting groups. This orthogonal protection scheme allows for selective deprotection of the N-terminal Fmoc group during chain assembly while maintaining the Dde protection on the side chain amino group. Consequently, researchers can achieve site-specific functionalization of the DAB residue after peptide synthesis is complete, enabling the creation of branched peptides, cyclic structures, or conjugates with fluorophores or other probes.

Formation of Conformationally Constrained Peptides

DAB serves as an exceptional building block for introducing conformational constraints into peptide structures. When incorporated into peptide sequences, the gamma amino group can participate in cyclization reactions to form 5-membered lactam rings. Research has demonstrated that Boc derivatives of 2,4-diaminobutyric acid can be used to synthesize cyclic dipeptides that serve as substrates for incorporation into proteins using modified ribosomal systems. These conformationally constrained analogues provide valuable tools for studying protein folding, enzyme-substrate interactions, and the structural requirements for biological activity. The ability to lock peptides into specific conformations through DAB-mediated cyclization has important implications for drug discovery and the development of peptide-based therapeutics.

Biological Significance and Pharmacological Activity of DAB

Interaction with GABAergic Systems

One of the most extensively studied biological activities of DAB relates to its interaction with the GABA neurotransmitter system. As a structural analogue of gamma-aminobutyric acid, DAB acts as an inhibitor of sodium-dependent GABA uptake in neuronal tissues. This property has made DAB-containing peptides valuable pharmacological tools for investigating GABAergic neurotransmission and developing potential therapeutic agents for neurological disorders. The stereospecificity of this inhibition, with the S(+) isomer being substantially more potent, highlights the importance of chiral purity in DAB-based research compounds.

Anticancer Properties

Emerging evidence suggests that DAB possesses antitumoral activity, particularly against glioma cells. The compound is transported into cells by the System A amino acid transporter, and its concentrated uptake in glioma cells can lead to osmotic lysis. This mechanism exploits the enhanced metabolic demands of cancer cells and their increased expression of amino acid transporters. The potential for DAB to serve as a selective anticancer agent, especially against brain tumors, represents an exciting avenue for therapeutic development. Researchers exploring this application rely on custom peptide synthesis services to create DAB-containing compounds with optimized pharmacokinetic properties.

Find out about high-speed RUSH synthesis.

Frequently Asked Questions (FAQ)

What is the difference between 2,4-diaminobutyric acid and ornithine?

Both are diamino acids, but they differ in chain length. 2,4-Diaminobutyric acid (DAB) has a four-carbon backbone with amino groups at positions 2 and 4, whereas ornithine has a five-carbon backbone with amino groups at positions 2 and 5. This structural difference affects the ring size when forming cyclic derivatives. DAB forms 5-membered lactams, while ornithine forms 6-membered rings.

Why is orthogonal protection necessary for DAB in peptide synthesis?

DAB contains two chemically similar amino groups that must be selectively deprotected during SPPS. Orthogonal protecting groups like Dde and Fmoc allow researchers to remove one protecting group without affecting the other, enabling precise control over where modifications occur. This is essential for creating branched peptides, cyclic structures, or site-specifically labeled conjugates.

Can DAB be incorporated into peptides for therapeutic applications?

Yes, DAB-containing peptides have shown promise in various therapeutic contexts, particularly as anticancer agents targeting glioma cells and as pharmacological tools for studying GABAergic neurotransmission. However, researchers must carefully consider the stereoisomer used, as biological activity differs dramatically between L- and D-forms.

How does DAB affect peptide conformation?

The dual amino groups of DAB enable the formation of intramolecular lactam bridges, creating conformationally constrained cyclic peptides. These constraints can stabilize specific secondary structures, such as turns or helices, and provide insights into the bioactive conformations required for target interactions.

JOHNSTON, G. A. R., & TWITCHIN, B. (1977). STEREOSPECIFICITY OF 2,4‐DIAMINOBUTYRIC ACID WITH RESPECT TO INHIBITION OF 4‐AMINOBUTYRIC ACID UPTAKE AND BINDING. British Journal of Pharmacology, 59(1), 218–219. https://doi.org/10.1111/j.1476-5381.1977.tb06998.x

Zhang, C., Bai, X., Dedkova, L. M., & Hecht, S. M. (2020). Protein synthesis with conformationally constrained cyclic dipeptides. Bioorganic & Medicinal Chemistry, 28(22), 115780. https://doi.org/10.1016/j.bmc.2020.115780

Batoon, P., & Ren, J. (2015). Proton affinity of dipeptides containing alanine and diaminobutyric acid. International Journal of Mass Spectrometry, 378, 151–159. https://doi.org/10.1016/j.ijms.2014.07.025

Fluorescent Labeling with Abz, where Abz stands for 2-aminobenzoyl, is an indispensable technique in biochemical and pharmacological research, particularly for studying enzyme kinetics and protein interactions. As a highly efficient fluorescent donor, Abz is renowned for its optimal spectral properties, including significant Stokes shift and high quantum yield, which facilitate sensitive detection in complex biological matrices. Its primary utility lies in Fluorescence Resonance Energy Transfer (FRET)-based assays, where it is paired with quenchers like 3-nitro-tyrosine (Tyr(NO2)) or 2,4-dinitrophenyl (Dnp) to create sensitive substrates for proteolytic enzymes. Consequently, this powerful labeling strategy enables real-time monitoring of protease activity, precise determination of kinetic parameters, and high-throughput screening of potential therapeutic inhibitors.

Key Takeaways

• Abz is an excellent fluorescent donor in FRET systems owing to its favorable photophysical properties, including a high quantum yield and a favorable Stokes shift.
• It is most commonly used in donor-quencher pairs (e.g., Abz/Dnp or Abz/Tyr(NO2)) to create fluorogenic substrates for monitoring protease activity.
• Fluorescence quenching in these substrates is relieved upon enzymatic cleavage, generating a measurable increase in fluorescence intensity.
• Abz-labeled peptides are crucial tools for studying enzymes like ACE (Angiotensin-Converting Enzyme) and various matrix metalloproteinases (MMPs).
• The site-specific incorporation of Abz during solid-phase peptide synthesis (SPPS) allows for the custom design of sensitive and specific assay probes.

Fundamentals of the Abz Fluorophore

Chemical Structure and Spectral Properties

The 2-aminobenzoyl (Abz) group is a derivative of anthranilic acid. Its structure features an aromatic benzene ring coupled with an electron-donating amino group, which is responsible for its strong fluorescence. Abz is typically excited in the near-ultraviolet to blue region, with a maximum absorbance around 320 nm, and emits blue fluorescence with a peak around 420 nm. This separation between excitation and emission wavelengths, known as the Stokes shift, is advantageous as it minimizes interference from scattered excitation light, thereby enhancing signal-to-noise ratios in assays.

The Principle of FRET and Quenching

The exceptional utility of Abz arises from its role in fluorescence quenching mechanisms. In a typical application, the Abz fluorophore is chemically incorporated into a peptide sequence at one site, while a suitable quencher molecule is attached at another. When in close proximity, the energy from the excited Abz is non-radiatively transferred to the quencher, resulting in low background fluorescence. This intact, quenched molecule serves as a fluorogenic substrate. Upon cleavage by a specific protease at the site between the donor and quencher, the physical separation disrupts the energy transfer. This disruption leads to a dramatic increase, often a 20 to 30-fold enhancement, in Abz fluorescence, which can be monitored in real-time.

Find out more about fluorescent peptides here.

Primary Applications in Biomedical Research

Monitoring Protease Activity and Kinetics

Abz-based fluorogenic substrates are a gold standard for studying proteolytic enzymes. The design is versatile: a target protease’s cleavage sequence is flanked by the Abz donor and an appropriate quencher. For example, substrates like Abz-FRK(Dnp)P-OH are specifically designed for the enzyme ACE (Angiotensin-Converting Enzyme), a key target in hypertension and heart failure research. The real-time increase in fluorescence directly correlates with enzyme activity, allowing researchers to calculate critical kinetic parameters, such as the Michaelis constant (Km) and the catalytic rate constant (kcat), with high precision and sensitivity.

High-Throughput Drug Screening

The sensitivity and adaptability of Abz-based assays make them ideal for high-throughput screening (HTS) platforms in drug discovery. Pharmaceutical companies and research laboratories routinely use these substrates to screen vast chemical libraries for potential inhibitors of disease-relevant proteases. Targets include renin (involved in blood pressure regulation), beta-secretase (BACE-1) (implicated in Alzheimer’s disease), and various cathepsins and matrix metalloproteinases (MMPs) associated with cancer metastasis and inflammatory diseases. The homogeneous, “mix-and-read” format of these assays significantly accelerates the discovery of lead compounds.

Investigating Protein-Protein Interactions

Beyond simple cleavage assays, the Abz fluorophore can be used in more sophisticated FRET-based binding studies. In this context, Abz is attached to one protein, while a compatible acceptor fluorophore (not a quencher) is attached to its binding partner. A change in FRET efficiency signals a binding event or a conformational change. This application is powerful for characterizing antibody-antigen interactions, studying receptor-ligand dynamics, and probing structural changes within large protein complexes.

Synthesis and Implementation

Incorporation into Peptide Sequences

The integration of the Abz group into peptides is achieved through standard solid-phase peptide synthesis (SPPS) protocols. Special Fmoc-protected Abz derivatives are commercially available and function like standard amino acids during the synthesis cycle. This allows for precise, site-specific incorporation at the N-terminus, the C-terminus, or even at internal positions within the peptide chain, providing immense flexibility in probe design. Specialized service providers, such as LifeTein, offer custom peptide synthesis with Abz and various quenchers, enabling researchers to obtain high-purity, assay-ready substrates without the need for in-house synthetic expertise.

Designing an Effective Substrate

Creating an optimal Abz-labeled substrate requires careful consideration:

1. Selection of Quencher: The quencher must have a strong spectral overlap with Abz’s emission. Dnp and Tyr(NO2) are classic, effective, and economical choices.
2. Cleavage Sequence: The peptide linker must contain the specific recognition and cleavage sequence for the target enzyme.
3. Length and Flexibility: The peptide must be long enough to allow efficient FRET when intact but should not hinder enzyme access to the cleavage site.

Find out more about peptide synthesis here.

Frequently Asked Questions (FAQ)

What does “Abz” stand for in peptide labeling?

Abz is the standard abbreviation for 2-aminobenzoyl, a fluorescent aromatic group derived from anthranilic acid. It functions as a highly efficient donor fluorophore in fluorescence-based assays.

How does an Abz/Dnp-labeled peptide work in a protease assay?

In an Abz/Dnp-labeled peptide, the Dnp group acts as a quencher for Abz fluorescence via FRET. When the intact peptide is excited, minimal fluorescence is detected. Upon cleavage by a specific protease between the two labels, they separate, FRET is abolished, and a strong increase in Abz fluorescence occurs, providing a direct measure of protease activity.

What are the main advantages of using Abz over other fluorophores like FAM or FITC?

Abz offers several key advantages: its larger Stokes shift reduces spectral interference, it is generally more photostable than fluorescein derivatives, and its excitation in the UV range can minimize background autofluorescence from biological samples, which is often excited at higher wavelengths.

Karaseva, M. A., Chukhontseva, K. N., Lemeskina, I. S., Pridatchenko, M. L., Kostrov, S. V., & Demidyuk, I. V. (2019). An Internally Quenched Fluorescent Peptide Substrate for Protealysin. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-50764-2

Bernegger, S., Brunner, C., Vizovišek, M., Fonovic, M., Cuciniello, G., Giordano, F., Stanojlovic, V., Jarzab, M., Simister, P., Feller, S. M., Obermeyer, G., Posselt, G., Turk, B., Cabrele, C., Schneider, G., & Wessler, S. (2020). A novel FRET peptide assay reveals efficient Helicobacter pylori HtrA inhibition through zinc and copper binding. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-67578-2

Keyhole limpet hemocyanin (KLH) is a well-established cornerstone in the generation of peptide-specific antibodies. As a large, highly immunogenic carrier protein sourced from the marine mollusk Megathura crenulata, its primary function is to provide the necessary T-cell help that small, weakly immunogenic peptide antigens lack on their own. The covalent conjugation of your peptide to KLH is often the decisive step in transforming a simple sequence into a potent immunogen capable of eliciting a robust and high-titer antibody response. However, this strategy is not universally optimal; a successful outcome hinges on understanding the benefits, potential pitfalls, and key alternatives before proceeding.

Key Takeaways

• KLH is a powerful immunogenic carrier that provides T-cell epitopes, essential for generating strong, class-switched antibody responses against small peptides.
• The primary goal of conjugation is to enhance immunogenicity. Keyhole limpet hemocyanin has been demonstrated as an optimal carrier, significantly outperforming other proteins in eliciting peptide-specific antibodies in comparative studies.
• A significant drawback is the “carrier effect,” where the immune system can disproportionately target KLH-derived epitopes or terminal peptide “neo-epitopes,” potentially reducing the yield of antibodies against the core peptide of interest.
• Strategic peptide design is critical. LifeTein recommends targeting solvent-exposed, flexible regions (often C- or N-terminal), using sequences of 8-20 amino acids, and managing hydrophobicity for solubility.
• A key alternative is the Multiple Antigenic Peptide (MAP) system, which uses a branched lysine core to present multiple peptide copies without a biological carrier, thereby avoiding anti-carrier antibodies and focusing the response on the peptide.

What is KLH and Why is it Used?

KLH is a high-molecular-weight, copper-containing glycoprotein renowned for its strong immunogenicity and low toxicity in animals and humans. Its effectiveness stems from its size and complex structure, which are rich in foreign epitopes that can be recognized by helper T cells of the host immune system. Peptides, especially those shorter than 20 amino acids, are typically too small to be efficiently recognized by B cells and lack the necessary T-cell epitopes to stimulate a mature, high-affinity IgG response. By conjugating the peptide to Keyhole limpet hemocyanin, you effectively “piggyback” its presentation onto a protein that efficiently engages both arms of the adaptive immune system, leading to enhanced antibody titers and isotype maturation (e.g., increased IgG1).

The Compelling Benefits of KLH Conjugation

Superior Immunogenic Potency

Extensive research validates KLH’s role as the benchmark carrier. A pivotal study comparing carrier proteins for cancer antigen vaccines concluded that the covalent attachment to KLH was optimal for inducing potent antibody responses. Recent methodologies further leverage KLH’s potency by combining it with rational peptide sequence optimization, demonstrating that KLH-conjugated, engineered peptides elicit stronger antibody titers and improved affinity against native target sequences.

Find more peptide conjugation here.

Proven Conjugation Chemistry

Reliable, kit-based methods exist for conjugating peptides to KLH. The two most common strategies are:

• Maleimide Chemistry: Used for peptides with a terminal cysteine residue. The thiol group of cysteine forms a stable thioether bond with a maleimide-activated KLH molecule.
• Carbodiimide (EDC) Chemistry: Used to conjugate peptides via carboxyl-to-amine crosslinking, typically targeting the N-terminus or lysine side chains of the peptide to lysines on KLH.
  These standardized protocols yield consistent conjugation efficiencies, allowing for predictable immunogen preparation.

Critical Considerations and Potential Drawbacks

The Carrier-Specific Response and Neo-Epitope Problem

A major consideration is that the immune system will also generate a vigorous response against KLH itself. This “carrier effect” is not inherently problematic but must be accounted for in assay design. More importantly, research indicates that antibodies raised against peptide-KLH conjugates can be disproportionately directed against the terminal amino acids of the peptide (the linkage region), creating “neo-epitopes” not present in the native, full-length protein. This can result in antisera with poor recognition of the target protein, as the most immunogenic part of the immunogen (the peptide terminus) is irrelevant to the final application.

Solubility and Handling Challenges

Keyhole limpet hemocyanin is notorious for its limited solubility, which can complicate conjugation and handling. While commercial formulations like PEGylated KLH improve solubility, this adds an extra layer of complexity. Furthermore, the large size of the KLH-peptide conjugate can sometimes cause steric hindrance, potentially masking the very epitope you aim to target, especially if it is internal rather than terminal.

Making the Decision: A Framework for Your Project

The choice to use KLH should be guided by your specific experimental goals and the nature of your peptide.

The Multiple Antigenic Peptide (MAP) Alternative

A powerful alternative to carrier conjugation is the Multiple Antigenic Peptide (MAP) system. This involves synthesizing your peptide on a branched lysine core, creating a macromolecule where the peptide itself constitutes up to 95% of the mass. MAPs are intrinsically immunogenic due to their size and high epitope density, requiring no foreign carrier protein. This eliminates the anti-KLH response and focuses the immune system entirely on the peptide antigen, which can be advantageous for generating highly specific antibodies.

Find out more about peptide synthesis here.

Frequently Asked Questions (FAQ)

Is KLH safe to use for immunization?

Yes. KLH is widely used in both research and clinical settings due to its high immunogenicity and low toxicity. It has been employed in human cancer vaccine trials and as an immunomodulator for decades.

How many peptides should I conjugate to each KLH molecule?

A high ratio is standard. Protocols often use a molar ratio of 80:1 (peptide:KLH) or similar to ensure the carrier surface is densely decorated with hapten, maximizing B-cell receptor engagement. Commercial activation kits are optimized to provide a high number of conjugation sites per KLH molecule.

Can I use something other than KLH as a carrier?

Yes, other proteins like bovine serum albumin (BSA) or ovalbumin (OVA) are common. However, KLH is generally preferred for primary immunization due to its superior foreignness and immunogenicity. BSA or OVA are often used as coating antigens in assay development to avoid detecting anti-carrier antibodies from the serum.

Where can I get help designing my peptide antigen and conjugation strategy?

Specialized peptide service providers like LifeTein offer free bioinformatics tools and expert support for peptide antigen design, considering factors like solubility, hydrophilicity, and conjugation site selection to maximize your chances of success.

References:

Chen, C.-H., Chiu, Y.-C., Huang, K.-Y., Huang, H.-H., Kuo, T.-W., Liu, Y.-C., Kao, H.-J., Yu, C.-L., Weng, S.-L., & Liao, K.-W. (2025). A Reproducible Sequence-Level Strategy to Enhance Peptide Immunogenicity While Preserving Wild-Type Epitope Recognition. Antibodies, 14(4), 106. https://doi.org/10.3390/antib14040106

Aarntzen, E. H. J. G., de Vries, I. J. M., Göertz, J. H., Beldhuis-Valkis, M., Brouwers, H. M. L. M., van de Rakt, M. W. M. M., van der Molen, R. G., Punt, C. J. A., Adema, G. J., Tacken, P. J., Joosten, I., & Jacobs, J. F. M. (2012). Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters. Cancer Immunology, Immunotherapy, 61(11), 2003–2011. https://doi.org/10.1007/s00262-012-1263-z

Kim, S. K., Ragupathi, G., Cappello, S., Kagan, E., & Livingston, P. O. (2000). Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1–KLH and GD3–KLH conjugates. Vaccine, 19(4–5), 530–537. https://doi.org/10.1016/s0264-410x(00)00195-x

Pon, R., Marcil, A., Chen, W., Gadoury, C., Williams, D., Chan, K., Zhou, H., Ponce, A., Paquet, E., Gurnani, K., Chattopadhyay, A., & Zou, W. (2020). Masking terminal neo-epitopes of linear peptides through glycosylation favours immune responses towards core epitopes producing parental protein bound antibodies. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-75754-7

Oyelaran, O., & Gildersleeve, J. C. (2010). Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray. PROTEOMICS – Clinical Applications, 4(3), 285–294. https://doi.org/10.1002/prca.200900130

Octahydroindole-2-carboxylic acid (Oic) is a prominent non-proteinogenic, bicyclic amino acid that has become an indispensable tool in advanced peptide design and peptidomimetic chemistry. As a conformationally constrained analogue of proline, Oic introduces significant backbone rigidity and enhanced lipophilicity when incorporated into peptide sequences. These properties are strategically employed to overcome major limitations of therapeutic peptides, such as poor metabolic stability and low bioavailability, by stabilizing specific secondary structures and improving membrane permeability. Consequently, Oic serves as a critical building block in pharmaceuticals, notably in antihypertensive drugs like perindopril and trandolapril, and in clinical-stage compounds for conditions ranging from hereditary angioedema to neurodegenerative diseases.

Key Takeaways

• Conformational Constraint: Oic’s bicyclic structure imparts significant rigidity to the peptide backbone, effectively stabilizing turns and helices and drastically reducing conformational flexibility.
• Enhanced Lipophilicity: The fused cyclohexane ring increases the hydrophobic character of the amino acid, which can improve a peptide’s passive membrane permeability and overall bioavailability.
• Stereochemical Complexity: With three stereogenic centers, Oic has eight possible stereoisomers. The (2S,3aS,7aS)-isomer (L-Oic) is the most prevalent in drug applications, with each isomer offering unique conformational properties.
• Synthetic Accessibility: Oic is used in peptide synthesis via commercially available, orthogonally protected derivatives like Fmoc-L-Oic-OH and Boc-L-Oic-OH, which are compatible with standard solid-phase peptide synthesis (SPPS) protocols.
• Proteolytic Stability: Peptides incorporating Oic exhibit increased resistance to enzymatic degradation, as the rigid structure and non-natural character hinder protease recognition and cleavage.

Chemical Structure and Fundamental Properties

Octahydroindole-2-carboxylic acid features a bicyclic system comprising a proline-like pyrrolidine ring fused to a cyclohexane ring. This structure classifies it as a bicyclic proline analogue. The complete saturation of the system (octahydro-) contributes to its high lipophilicity compared to standard amino acids.

A key feature of Oic is its stereochemical complexity. The molecule possesses three chiral centers (at the 2, 3a, and 7a positions), leading to eight possible stereoisomers. The specific (2S,3aS,7aS) configuration, known as L-Oic, is the isomer most commonly employed in pharmaceutical and peptide research due to its commercial availability and proven utility in bioactive compounds. The stereochemistry at these centers critically influences the three-dimensional orientation of the cyclohexane ring, which in turn dictates the conformational impact Oic exerts on a peptide chain.

Find out more about peptide synthesis here.

Conformational Impact on Peptide Structure

Induction of Backbone Rigidity

The primary structural effect of incorporating Oic is the severe restriction of the φ and ψ backbone dihedral angles at the site of incorporation. This backbone rigidity reduces the entropic penalty upon binding to a target and helps pre-organize the peptide into a bioactive conformation.

Stabilization of Polyproline II Helices

Research has demonstrated that oligomers of Oic spontaneously form stable polyproline type II (PPII) helices, which are extended, left-handed helical structures. The fused cyclohexane ring in a chair conformation anchors the pyrrolidine ring in an exo puckering, which strongly favors the trans configuration of the preceding amide bond. This preference propagates through the chain, leading to a cooperative stabilization of the entire PPII helix. This makes Oic an ideal building block for constructing stable, hydrophobic PPII scaffolds, which are relevant in molecular recognition and biomaterial science.

Promotion of Beta-Turns

In shorter peptide sequences, Oic is exceptionally effective at nucleating and stabilizing beta-turn structures, particularly type II’ β-turns. Its constrained geometry perfectly accommodates the *i+1* or *i+2* position of a turn, making it a valuable tool for cyclizing peptides or mimicking surface loops of proteins in drug design.

Synthesis and Incorporation into Peptides

Synthetic Routes to Oic

The synthesis of enantiomerically pure Oic, especially non-commercial stereoisomers, presents a considerable challenge due to its three stereocenters. Methodologies reported in the literature include:

• Stereoselective synthesis from chiral precursors.
• Diastereomeric resolution of racemic mixtures via salt formation or chromatography.
• Epimerization and selective functionalization strategies, such as the formation of a trichloromethyloxazolidinone derivative to separate epimers.
  Industrial routes, as detailed in patents for drugs like trandolapril, often involve multi-step sequences starting from materials like L-serine or indoline-2-carboxylic acid.

Use in Solid-Phase Peptide Synthesis (SPPS)

For peptide chemists, Oic is readily incorporated using standard Fmoc-SPPS or Boc-SPPS strategies. The amino acid is commercially available in forms suitable for these techniques:

These derivatives ensure efficient and selective incorporation into growing peptide chains on automated synthesizers.

Applications in Pharmaceutical and Peptide Science

Oic’s unique properties have led to its successful integration into several high-profile therapeutic agents:

• Antihypertensive Drugs: Oic is the key dipeptide mimic in perindopril and trandolapril, both angiotensin-converting enzyme (ACE) inhibitors. Its rigid structure is critical for potent enzyme binding.
• Bradykinin B2 Receptor Antagonists: The drug icatibant (HOE 140), used to treat hereditary angioedema, contains Oic as a substitute for proline, conferring potent antagonism and high metabolic stability.
• Enzyme Inhibitors: Oic-based compounds like S 17092 are potent inhibitors of prolyl oligopeptidase (POP), a target for cognitive disorders, showcasing their utility in neuropharmacology.
• Peptidomimetic Design: Beyond direct incorporation, Oic serves as a versatile core structure for designing quaternary amino acid derivatives and other functionalized scaffolds with potential applications in treating joint cartilage damage and as antithrombotic agents.

Find out about high-speed RUSH synthesis.

Frequently Asked Questions (FAQ)

What is the main advantage of using Oic over proline in a peptide?

While both induce conformational constraint, Oic provides significantly greater backbone rigidity and lipophilicity due to its fused, saturated bicyclic structure. This often translates to superior proteolytic stability and enhanced bioavailability in peptide-based therapeutics.

Can Oic be used in standard automated peptide synthesizers?

Yes, absolutely. The commercially available Fmoc-L-Oic-OH and Boc-L-Oic-OH derivatives are fully compatible with standard solid-phase peptide synthesis (SPPS) protocols and coupling reagents, allowing for seamless integration into automated synthesis workflows.

Why is the stereochemistry of Oic so important?

The three-dimensional shape of Oic, dictated by its three stereocenters, determines how it influences peptide folding. Different stereoisomers will project the fused cyclohexane ring in distinct spatial orientations, which can either stabilize or destabilize a desired peptide conformation and dramatically affect binding to a biological target.

Is Oic a natural amino acid?

No, octahydroindole-2-carboxylic acid is a non-proteinogenic, synthetic amino acid. It is not encoded by DNA and is not found in naturally occurring ribosomal proteins, though motifs similar to its structure exist in some complex natural products like aeruginosins.



Sayago, F. J., Isabel Calaza, M., Jiménez, A. I., & Cativiela, C. (2008). Versatile methodology for the synthesis and α-functionalization of (2R,3aS,7aS)-octahydroindole-2-carboxylic acid. Tetrahedron, 64(1), 84–91. https://doi.org/10.1016/j.tet.2007.10.095

Sayago, F. J., Jiménez, A. I., & Cativiela, C. (2007). Efficient access to N-protected derivatives of (R,R,R)- and (S,S,S)-octahydroindole-2-carboxylic acid by HPLC resolution. Tetrahedron: Asymmetry, 18(19), 2358–2364. https://doi.org/10.1016/j.tetasy.2007.09.006

Fluorescent labelling is a cornerstone technique for visualizing and quantifying biomolecular interactions, with 7-Methoxycoumarin-4-acetic acid (MCA) standing out as a particularly versatile fluorophore for peptide applications. As a coumarin-derived dye, MCA is prized for its favorable photophysical properties and its specialized role in constructing sensitive, internally quenched substrates. Its primary utility lies in Fluorescence Resonance Energy Transfer (FRET)-based assays, where it acts as a donor fluorophore paired with a suitable quencher. This configuration allows for the real-time, continuous monitoring of enzymatic activity, making MCA-labeled peptides indispensable tools in protease research, drug discovery, and cellular biology. Companies like LifeTein provide expert synthesis of these complex probes, enabling researchers to tailor substrates for specific experimental needs.

Key Takeaways

• MCA is a coumarin-based fluorescent dye with excitation/emission maxima in the near-UV to blue spectrum, ideal for FRET applications.
• Its primary application is in creating internally quenched FRET substrates, where it is paired with quenchers like DNP (2,4-Dinitrophenyl) to measure protease activity.
• Conjugation to peptides is typically achieved via its succinimidyl ester derivative, allowing for stable attachment to the N-terminus or lysine side chains.
• These assays offer high sensitivity, real-time kinetic data, and the ability to work with nanomolar enzyme concentrations.
• Custom synthesis services, such as those from LifeTein, are crucial for producing sequence-specific MCA-peptide conjugates with high purity for reliable research outcomes.

Photophysical and Chemical Profile of MCA

Spectral Characteristics

MCA exhibits classic coumarin fluorescence, with absorption and emission peaks in the near-ultraviolet to blue light range. Reported maxima can vary slightly depending on the solvent environment; for instance, in methanol, peaks are observed at approximately 320 nm (absorption) and 380 nm (emission). In aqueous buffers and when conjugated to peptides, these values may shift, with common references citing excitation at 328-360 nm and emission at 393-410 nm. This spectral profile minimizes interference from biological autofluorescence, which is typically higher at longer wavelengths, thereby providing a low-background signal for detection.

Conjugation Chemistry

For practical use, MCA is activated as a succinimidyl ester (MCA-OSu), a reactive form that facilitates efficient conjugation to peptides. This chemistry targets primary amine groups, primarily the N-terminal α-amino group or the ε-amino group of lysine residues. The reaction forms a stable amide bond, incorporating the fluorophore directly into the peptide backbone. This site-specific labelling is critical for maintaining the peptide’s biological activity and for ensuring consistent fluorescence properties across batches.

Find out more about fluorescent peptides here.

Primary Applications in Peptide-Based Research

The Foundation of FRET-Based Protease Assays

The most significant application of MCA is in the development of FRET-based peptide substrates for protease analysis. In these constructs, MCA is covalently attached to one end of a peptide sequence that contains the specific cleavage site for a target enzyme. A quencher molecule, most commonly DNP, is attached to the opposite end. When the peptide is intact, the close proximity of the quencher absorbs the energy emitted by the excited MCA donor, resulting in fluorescence quenching. Upon protease cleavage, the physical separation of MCA and the quencher abolishes this energy transfer, leading to a dramatic increase in MCA fluorescence that is directly proportional to enzymatic activity.

A Practical Example: Monitoring Mitochondrial Protease OMA1

A clear illustration of this principle is found in research on the mitochondrial protease OMA1. To study this enzyme, researchers employed a custom peptide substrate: MCA-AFRATDHG-(Lys)DNP. This sequence contains the precise cleavage site of OMA1 within the OPA1 protein. In the intact peptide, DNP quenches MCA fluorescence. When OMA1 cleaves the peptide between arginine and alanine, the fluorescence is dequenched, providing a direct, spectrophotometric readout of OMA1 activity. This assay enabled the first direct activity measurements for OMA1, showcasing how MCA-labeled peptides can unlock the study of previously challenging enzymes.

Versatility Across Protease Families

The MCA/DNP pair is not limited to a single enzyme. It is a standardized tool for investigating a wide array of proteolytic enzymes, including matrix metalloproteinases (MMPs), caspases, and viral proteases. For example, a classic substrate for stromelysin (MMP-3) is MCA-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH₂. The modular design of these peptides allows researchers to easily swap the central cleavage sequence to target different proteases, making MCA a universal component in the protease researcher’s toolkit.

Considerations for Implementing MCA Labelling

Design and Synthesis

Successful assay development begins with careful peptide design. The cleavage sequence must be specific to the target protease, and the positioning of the MCA and quencher must ensure efficient FRET in the uncleaved state. Given the complexity of synthesizing and purifying these dual-modified peptides, partnering with a specialized provider like LifeTein is highly advantageous. Their expertise ensures high-purity products, which are essential for obtaining reliable, reproducible kinetic data and minimizing background signal.

Practical Assay Considerations

When running assays, researchers must optimize buffer conditions (pH, ionic strength) to support both enzyme activity and fluorescent signal stability. Establishing a standard curve with free MCA is necessary to quantify the amount of cleaved product. Furthermore, control experiments with enzyme inhibitors are crucial to confirming that the observed fluorescence increase is due to specific proteolytic cleavage.

Find out more about peptide synthesis here.

Frequently Asked Questions (FAQ)

What makes MCA particularly suitable for protease assays?

MCA is ideal because its emission spectrum overlaps strongly with the absorption spectrum of common quenchers like DNP, enabling highly efficient FRET quenching. Its photostability and the significant fluorescence increase upon cleavage make it excellent for sensitive, continuous kinetic measurements.

Can MCA be used for live-cell imaging?

While possible, MCA is less common for live-cell imaging compared to longer-wavelength dyes like GFP or Cy5. Its excitation in the UV/blue range can cause higher cellular autofluorescence and phototoxicity. However, it can be effective for in vitro or fixed-cell applications where its spectral properties are advantageous.

What is the difference between MCA and other coumarin dyes like AMC?

MCA (7-Methoxycoumarin-4-acetic acid) contains a carboxylic acid group for covalent conjugation to peptides. In contrast, AMC (7-Amino-4-methylcoumarin) is a cleavage product of many fluorogenic substrates but is not typically used for direct peptide labelling, as it lacks the same convenient reactive handle.

Are there alternatives to the MCA/DNP FRET pair?

Yes, several other FRET pairs are widely used. Common alternatives include EDANS/DABCYL (which operates at longer wavelengths) and FAM/Dabcyl. The choice of pair depends on the available instrument filters, the required sensitivity, and potential sample-induced interference.

Tobacyk, J., Parajuli, N., Shrum, S., Crow, J. P., & MacMillan-Crow, L. A. (2019). The first direct activity assay for the mitochondrial protease OMA1. Mitochondrion, 46, 1–5. https://doi.org/10.1016/j.mito.2019.03.001

Propargylglycine (Pra) is a prominent unnatural amino acid that has become an indispensable tool in chemical biology and peptide engineering. Classified as a non-proteinogenic building block, it is not incorporated into proteins by the ribosomal machinery but is instead used synthetically to bestow novel chemical and biological properties upon peptides. Its defining feature is a terminal alkyne moiety (-C≡CH) appended to the side chain of glycine, creating a versatile handle for bioorthogonal chemistry. This simple yet powerful modification enables Pra to serve dual roles: as a potent, mechanism-based inhibitor of key enzymes in sulfur metabolism and as a unique chemical tag for precise, site-specific modification of biomolecules.

Key Takeaways

• Pra features a terminal alkyne side chain, making it a cornerstone for Cu-catalyzed azide-alkyne cycloaddition (CuAAC) “click chemistry” in peptide and protein labeling.
• It acts as a potent and irreversible inhibitor of the enzyme cystathionine γ-lyase (CSE), a key player in the endogenous production of hydrogen sulfide (H₂S).
• As an unnatural amino acid, Pra is used to expand the functional repertoire of synthetic peptides, allowing for the installation of probes, tags, and stabilizers to enhance their utility in research and drug discovery.

Fundamentals of Propargylglycine

Chemical Structure and Properties of Pra

Propargylglycine, with the molecular formula C₅H₇NO₂ and a molecular weight of 113.1 g/mol, is the simplest alkyne-bearing amino acid. Its IUPAC name is 2-amino-4-pentynoic acid. Structurally, it is an analog of the natural amino acid glycine, where one hydrogen on the alpha-carbon is replaced by a propargyl group (-CH₂-C≡CH). This L-configuration amino acid is typically supplied as a white to light-yellow crystalline powder. The presence of the terminal alkyne is central to all its applications, providing a site of unique chemical reactivity absent from the canonical 20 amino acids.

The Dual Roles of Propargylglycine (Pra)

Propargylglycine (Pra) as A Potent Biochemical Inhibitor

One of the most well-established applications of Pra, particularly its D,L-form, is as a mechanism-based enzyme inhibitor. It is a specific and potent inhibitor of cystathionine γ-lyase (CSE), with a reported half-maximal inhibitory concentration (IC₅₀) of approximately 40 µM. CSE is a pivotal enzyme in the transsulfuration pathway, responsible for the endogenous production of the gaseous signaling molecule hydrogen sulfide (H₂S). By irreversibly inhibiting CSE, Pra becomes a crucial pharmacological tool for studying the complex physiological and pathological roles of H₂S in systems ranging from cardiovascular function and neuroscience to inflammation and cancer metabolism.

Find out more about peptide synthesis here.

A Versatile Handle for Bioorthogonal Chemistry

Beyond its inhibitory function, the true power of Pra in synthetic chemistry lies in its alkyne functional group. This group participates efficiently in the Cu-catalyzed azide-alkyne cycloaddition (CuAAC), a premier example of “click chemistry”. This reaction is highly selective, proceeds rapidly under mild conditions, and is virtually inert to other biological functional groups, making it bioorthogonal. Consequently, peptides or proteins incorporating Pra can be selectively and covalently “tagged” with any molecule carrying an azide group, such as fluorescent dyes, biotin, polymers, or other peptides.

Propargylglycine (Pra) in Peptide Science and Engineering

Pra Incorporation into Synthetic Peptides

Pra is routinely incorporated into peptides using standard solid-phase peptide synthesis (SPPS) methodologies. Specialized peptide synthesis service providers can include Pra and other unnatural amino acids into custom sequences to meet specific research needs. The incorporation is straightforward, treating Pra as a unique building block during the sequential assembly of the peptide chain. This allows researchers to precisely control the location of the reactive alkyne handle within the peptide structure.

Enabling Advanced Peptide Ligand Design

A sophisticated application of Pra is in the rational design of high-affinity peptide ligands. A novel strategy involves the single-point substitution of a lysine residue with Pra within a peptide sequence. Following synthesis, the alkyne of Pra is used to attach an aminophilic salicylaldehyde tag via CuAAC. This tag can then form a reversible covalent bond with a lysine residue on the target protein’s surface. This approach has been successfully demonstrated to enhance the affinity of a peptide for its target, NEMO, showcasing a powerful method to convert standard peptides into potent, reversible-covalent binders.

Pra Advantages in Peptide Therapeutic Optimization

The use of unnatural amino acids like Pra aligns with broader strategies in peptide drug discovery to overcome inherent limitations of natural peptides, such as poor metabolic stability and low membrane permeability. Introducing Pra can modulate a peptide’s physicochemical properties, alter its conformation, and provide a direct avenue for conjugation to half-life extending polymers (like PEG) or drug carriers. Furthermore, the alkyne handle can be used to install environment-sensitive fluorophores for imaging or tracking, as noted in studies with cystine knot peptides.

Find out about high-speed RUSH synthesis.

Frequently Asked Questions (FAQ)

What makes Propargylglycine an “unusual” or “unnatural” amino acid?

Propargylglycine is classified as unnatural or non-proteinogenic because its structure, featuring an alkyne side chain, does not exist among the 20 standard amino acids encoded by DNA and used in natural ribosomal protein synthesis. It is a product of synthetic chemistry designed to provide functionalities not available in nature.

Is Pra’s primary use as an inhibitor or a chemical handle?

It serves both critical functions, and the primary use depends on the research context. In physiological and pharmacological studies, its role as a CSE inhibitor to probe H₂S biology is paramount. In chemical biology, biotechnology, and drug discovery, its utility as a bioorthogonal click chemistry handle for labeling and conjugating biomolecules is its key asset.

How is Pra incorporated into peptides?

Pra is incorporated synthetically. The most common method is solid-phase peptide synthesis, where it is used as a protected amino acid building block and coupled in sequence like any standard amino acid. For producing more complex proteins, advanced techniques like genetic code expansion in live cells can be used to incorporate Pra site-specifically.

Can Pra be purchased for research?

Yes, L-Propargylglycine is commercially available from fine chemical and biochemical suppliers. It is typically sold as a high-purity (e.g., ≥98%) powder for research use.

Adhikari, A., Bhattarai, B. R., Aryal, A., Thapa, N., KC, P., Adhikari, A., Maharjan, S., Chanda, P. B., Regmi, B. P., & Parajuli, N. (2021). Reprogramming natural proteins using unnatural amino acids. RSC Advances, 11(60), 38126–38145. https://doi.org/10.1039/d1ra07028b

Sharma, K. K., Sharma, K., Rao, K., Sharma, A., Rathod, G. K., Aaghaz, S., Sehra, N., Parmar, R., VanVeller, B., & Jain, R. (2024). Unnatural Amino Acids: Strategies, Designs, and Applications in Medicinal Chemistry and Drug Discovery. Journal of Medicinal Chemistry, 67(22), 19932–19965. https://doi.org/10.1021/acs.jmedchem.4c00110

Tryptophan is an essential amino acid, meaning the human body cannot synthesize it and must obtain it through diet. It serves as a critical building block for proteins and a precursor to key molecules, most notably the neurotransmitter serotonin and the hormone melatonin. This biochemical relationship to sleep-regulating compounds is the foundation of tryptophan’s popular reputation as a drowsiness-inducing agent, particularly in the context of holiday turkey consumption. However, the biological reality of how tryptophan affects sleep is more complex and nuanced than the common myth suggests. Furthermore, beyond its role in nutrition, tryptophan’s unique chemical structure makes it a valuable and versatile tool in the field of peptide synthesis and pharmaceutical development.

Key Takeaways

• The amount of tryptophan in a typical serving of turkey is not exceptional compared to other common poultry and meats, challenging the basis of the “Thanksgiving sleepiness” myth.
• Isolated, high-dose tryptophan supplementation can influence sleep by increasing serotonin and melatonin synthesis, but the tryptophan in a mixed meal does not typically cause immediate drowsiness.
• Tryptophan is the least abundant amino acid in proteins but plays critical structural and functional roles in bioactive peptides and therapeutic drugs.
• The indole side chain of tryptophan allows for unique chemical modifications, enabling scientists to fine-tune the properties of synthetic peptides for research and medicine.
• Late-stage functionalization techniques allow chemists to selectively modify tryptophan residues in complex peptides, creating analogs with improved stability or activity.

Demystifying the Dietary Myth of Tryptophan

The Thanksgiving Turkey Fallacy

A pervasive piece of popular folklore suggests that the tryptophan in Thanksgiving turkey is the primary reason for post-meal drowsiness. However, a closer examination of nutritional data reveals that the tryptophan content in turkey is typical for poultry. For instance, a skinless, boneless light meat turkey contains approximately 410 mg of tryptophan per pound, which is comparable to the 238 mg per pound found in chicken. Other foods, such as lamb shoulder roast, certain cheeses, and seeds like pumpkin and chia, can contain comparable or even higher concentrations of tryptophan per serving. Therefore, singling out turkey as an exceptional source of this amino acid is scientifically inaccurate.

The Biochemical Pathway to Sleep

The association between tryptophan and sleep is not entirely without merit; it is simply misunderstood in the context of a balanced meal. Tryptophan is a metabolic precursor in the synthesis of serotonin, a key neurotransmitter that regulates mood and sleep. In the brain, serotonin is subsequently converted into melatonin, a neurohormone that is critical for regulating sleep-wake cycles. Research confirms that consuming purified tryptophan supplements on an empty stomach can increase serotonin levels in the brain and decrease sleep latency (the time it takes to fall asleep). This is the factual core of the sleep connection. However, the post-Thanksgiving meal lethargy is more likely caused by the overall context of a large, carbohydrate-rich feast, which can trigger a blood sugar spike and subsequent crash, combined with the general physiological effort required for digestion.

Find out more about peptide synthesis here.

Tryptophan in Peptide Synthesis and Modification

A Scarce but Significant Amino Acid

In the realm of protein biosynthesis, tryptophan is encoded by a single codon (UGG) and is the least abundant amino acid in proteins, constituting only about 1% of their composition. Its biosynthesis is energetically costly, leading to the evolutionary principle that it is incorporated only where it provides a distinct functional or structural advantage. This low abundance but high importance extends to therapeutic peptides, where tryptophan often plays a critical role in ligand binding, enzyme catalysis, and signal transduction due to its unique chemical properties.

The Versatile Indole Ring

The functional power of tryptophan lies in its indole side chain, a large, planar, and electron-rich aromatic structure. This ring system allows tryptophan to participate in crucial cation-π interactions and π-π stacking effects, which are vital for stabilizing protein structures and mediating interactions with other molecules . Furthermore, the indole ring is relatively hydrophobic, influencing the overall solubility and folding of peptides that contain it. Predicting the solubility of tryptophan-containing peptides is a key step in research, and providers like LifeTein offer detailed protocols for dissolving hydrophobic peptides, often recommending organic solvents like DMSO or DMF for initial solubilization.

Late-Stage Functionalization for Drug Development

The unique chemical properties of the indole ring make it an excellent target for site-selective modification. Recent advances in synthetic chemistry have enabled late-stage functionalization, a powerful strategy that allows scientists to chemically modify a single tryptophan residue in a complex, fully-assembled peptide . This approach is more efficient than building the modified amino acid into the peptide from scratch.

For example, scientists have developed a catalyst-free method to add various functional groups, such as trifluoromethylthio (SCF₃) or difluoromethylthio (SCF₂H), to the tryptophan residue in a therapeutic peptide using trifluoroacetic acid (TFA) as a solvent. These modifications can significantly alter the peptide’s properties, potentially improving its metabolic stability, membrane permeability, and overall pharmacokinetic profile. These techniques are invaluable for creating diverse peptide libraries for drug discovery and for optimizing the properties of existing therapeutic peptides, a service area that companies like LifeTein specialize in through custom peptide synthesis and modification .

Find out about high-speed RUSH synthesis.

Frequently Asked Questions (FAQ)

Does eating turkey really make you sleepy?

While turkey contains tryptophan, the amount is not exceptional compared to other common meats. The drowsiness experienced after a large holiday meal is more likely due to the overall high caloric and carbohydrate intake, which diverts blood flow to the digestive system, rather than the specific effects of tryptophan from the turkey.

How does tryptophan actually affect sleep?

When consumed in isolated, high-dose supplements (1 gram or more), tryptophan can cross the blood-brain barrier and be converted into serotonin, which is then used to produce melatonin. This pathway can promote relaxation and reduce the time it takes to fall asleep. This effect is not typically produced by the tryptophan in a mixed meal.

Why is tryptophan important in peptide drugs?

Tryptophan is often found in the active sites of peptides and proteins due to its large, reactive indole ring. It is crucial for binding to targets and stabilizing structures. Modifying tryptophan residues allows researchers to create new peptide analogs with enhanced stability, activity, or other desirable drug-like properties.

What are some challenges in working with tryptophan-containing peptides?

Peptides with a high proportion of hydrophobic amino acids like tryptophan can be difficult to dissolve in aqueous solutions. LifeTein’s guidelines recommend using organic solvents like DMSO or DMF, or strong solvents like TFA, for initial solubilization of such hydrophobic peptides.

Richard, D. M., Dawes, M. A., Mathias, C. W., Acheson, A., Hill-Kapturczak, N., & Dougherty, D. M. (2009). L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. International Journal of Tryptophan Research, 2. https://doi.org/10.4137/ijtr.s2129

Xiao, Y., Zhou, H., Shi, P., Zhao, X., Liu, H., & Li, X. (2024). Clickable tryptophan modification for late-stage diversification of native peptides. Science Advances, 10(28). https://doi.org/10.1126/sciadv.adp9958

Mupparapu, N., Syed, B., Nguyen, D. N., Vo, T. H., Trujillo, A., & Elshahawi, S. I. (2024). Selective Late-Stage Functionalization of Tryptophan-Containing Peptides To Facilitate Bioorthogonal Tetrazine Ligation. Organic Letters, 26(12), 2489–2494. https://doi.org/10.1021/acs.orglett.4c00709